FGF23 and hyperphosphatemia: Since high levels of serum phosphate in CKD patients are accompanied by elevated FGF23 to combat hyperphosphatemia, we added FGF23 treatments to our phosphate + CSE treatments to see whether their previously shown proinflammatory responses were further exaggerated.